Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2003
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422663A Chinese medicine preparation for preventing and treating throat and oral cavity diseases and preparation method
06/11/2003CN1422655A Throat lozenge
06/11/2003CN1422633A Formula of suning-kechuantie-plaster for treating cough and asthma and production technology thereof
06/11/2003CN1422632A Instant powder for treating pharyngitis
06/11/2003CN1111061C Medicine for treating throat diseases and its preparing process
06/11/2003CN1111059C Medicine for treating asthma
06/11/2003CN1111051C Medicine for treating cough and asthma
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt
06/10/2003US6576669 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003US6576224 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
06/10/2003CA2284753C Throat soothing compositions
06/10/2003CA2265708C Lipoxin compounds and their use in treating cell proliferative disorders
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046553A1 Diagnostics for chronic obstructive pulmonary disease
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045938A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
06/05/2003WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045917A2 Ccr-3 receptor antagonists vii
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045407A1 A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
06/05/2003WO2003045406A1 An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045385A1 Benzothiazole derivatives
06/05/2003WO2003045383A1 Use of ppar activators for the treatment of pulmonary fibrosis
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045374A1 Treating asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
06/05/2003WO2003045363A2 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045332A2 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003WO2003045331A2 Formulations for oral administration of cromolyn sodium
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045229A2 Methods and compositions for treating cancer
06/05/2003WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
06/05/2003WO2002058713A8 Method for obtaining an isolated extract of the plant cyclamen europaeum l. and its use as a therapeutic agent
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003WO2002040673A3 Compositions and methods relating to lung specific genes and proteins
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105113 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl ] piperazine
06/05/2003US20030105112 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468344A1 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467874A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003CA2467825A1 Benzothiazole derivatives
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466863A1 Formulations for oral administration of cromolyn sodium
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2461816A1 Treating asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
06/05/2003CA2413315A1 Antithrombin for the prevention and therapy of vasculoproliferative disorders
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1316311A1 Therapeutic use on-demand of formoterol and budesonide
06/04/2003EP1315963A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 878